SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-191945
Filing Date
2023-07-24
Accepted
2023-07-24 09:16:29
Documents
15
Period of Report
2023-07-23
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d442693d8k.htm   iXBRL 8-K 35192
2 EX-10.1 d442693dex101.htm EX-10.1 6144
3 EX-99.1 d442693dex991.htm EX-99.1 10473
7 GRAPHIC g442693g0723224458613.jpg GRAPHIC 3793
  Complete submission text file 0001193125-23-191945.txt   187520

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA meip-20230723.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230723_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230723_pre.xml EX-101.PRE 11265
9 EXTRACTED XBRL INSTANCE DOCUMENT d442693d8k_htm.xml XML 3342
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231103887
SIC: 2834 Pharmaceutical Preparations